JesseEAdamsIIIMDFACC

PubMed

• 51 citations
  Elevations of CK-MB following pulmonary embolism. A manifestation of occult right ventricular infarction.
  Jesse E. Adams, Barry A. Siegel, James A. Goldstein, Allan S. Jaffe
  Chest. 1992-05-01
• 80 citations
  Warfarin dose adjustments based on CYP2C9 genetic polymorphisms.
  Mark W. Linder, Stephen W. Looney, Jesse Adams, Nancy A. Johnson, Deborah M. Antonino-Green
  Journal of Thrombosis and Thrombolysis. 2002-12-01
• 860 citations
  Cardiac troponin I. A marker with high specificity for cardiac injury.
  Jesse E. Adams, Geza S. Bodor, Victor G. Dávila-Román, James A. Delmez, Fred S. Apple
  Circulation. 1993-07-01

Books/Book Chapters

• Markers in Cardiology: A Case-Oriented Approach 
  Jesse Earl Adams, III, MDEditors: Jesse Earl Adams, III, MD.Blackwell, Malden, MA2007
• Markers in Cardiology: A Case-Oriented Approach 
  Chapter: So You Think You Have a "False Positive" Troponin? 
  Adams JE, Apple FS, Jaffe ASBlackwell, Malden, MA2007
• Markers in Cardiology: A Case-Oriented Approach 
  Chapter: Clinical Integration of C-reactive Protein for Primary and Secondary Risk Factor Stratification. 
  Adams JE, Apple FS, Jaffe ASBlackwell, Malden, MA2007
• Cardiovascular Biomarkers; Pathophysiology and Disease Management 
  Chapter: Emerging Markers of Myocardial Ischemia. 
  Adams JE, Morrow DAHumana Press, Totowa, NJ2006
• Diagnosis of Perioperative Myocardial Infarction in Cardiac Markers 
  Adams JEEditors: Wu A.Edition 2nd,2003
• Markers in Cardiology, Cardiovascular Toxicology 
  Page 81 - 176Jesse Earl Adams, III, MDEditors: Jesse Earl Adams, III, MD.2001
• Markers in Cardiology; Current and Future Clinical Applications 
  Jesse Earl Adams, III, MDEditors: Jesse Earl Adams, III, MD.Futura, Armonk, NY2000
• Markers in Cardiology; Current and Future Clinical Applications 
  Chapter: Cardiac and Noncardiac Surgery. 
  Jesse Earl Adams, III, MDEditors: Adams JE, Apple F, Jaffe A, Wu A.Futura, Armonk, NY2000
• Markers in Cardiology; Current and Future Clinical Applications 
  Chapter: Acute Coronary Syndromes: Pathophysiology, Clinical Presentation, and Initial Diagnostic Strategies. 
  Adams JE, Miracle VAEditors: Adams JE, Apple F, Jaffe A, Wu A.Futura, Armonk, NY2000
• Markers in Cardiology; Current and Future Clinical Applications 
  Chapter: Report on Survey of Analytical and Clinical Characteristics of Commercial Cardiac Troponin Assays. 
  Apple FS, Adams JE, Wu AHB, Jaffe ASEditors: Adams JE, Apple F, Jaffe A, Wu A.Futura, Armonk, NY2000
• Thrombosis, Embolism and Bleeding 
  Chapter: Scintigraphic and haematological detection of thrombosis and increased embolic risk. 
  Page 206 - 222Adams JE III, Jaffe ASEditors: Butchart and Bodnar.1993
• Join now to see all

Abstracts/Posters

• N-Terminal proB-type Natriuretic Peptide Concentration Predicts the Presence of Cardiovascular Disease.
  Ewald G, Waggoner A, Cole T, Nowatzke W, Berger S, J. Adams J, Kroll M, Clinical Chemistry, 1/1/2003
• Distribution of Serum NT-proBNP Concentrations in Healthy United States Sub-Populations from Eight Areas.
  Berger S, Cole TG, Nowatzke WL, Ewald GA, Adams JE, Kroll MH, Clinical Chemistry, 1/1/2003
• Correlation of Levels of NT-proBNP and NYHA Functional Classification in Patients with Congestive Heart Failure.
  Adams JE, Ewald G, Berger S, Kroll MH, Nowatzke WL, Cole TG, Clinical Chemistry, 1/1/2003
• Measurement of circulating levels of unbound free fatty acid (FFAu) using ADIFAB2.
  Kleinfeld AM, Kampf PJ, Adams JE, Clinical Chemistry, 1/1/2003
• Serum Levels of Unbound Free Fatty Acids Reveal High Sensitivity for Early Detection of Acute Myocardial Infarction in Patient Samples From the TIMI II Trial.
  Kleinfeld AM, Kleinfeld KJ, Adams JE, J Am Coll Cardiol, 1/1/2002
• Measurement of Levels of Unbound Free Fatty Acid Allows the Early Identification of Patients with Acute Coronary Syndromes.
  Adams JE, Kleinfeld A, Roe M, Yang H, Christenson RH, Ohman EM, Gibler WB, Circulation, 1/1/2002
• Use of Brain Naturetic Peptide in Cardiac Transplant Evaluation.
  Bhat G, Jevans A, Heichelbech J, Pidwell D, Adams JE, HFSA 5th Annual Scientific Meeting, 1/1/2001
• Use of cardiac troponin I to detect cardiac injury after cardiac surgery.
  Adams J.E. III, Jeavens A.W., Gray, L.A., Circulation, 1/1/1998
• Similar sensitivities of cardiac troponin I and MB creatine kinase for detection of acute myocardial infarction.
  Adams J.E. III, Ladenson J.H., Jaffe A.S., J Am Coll Cardiol, 1/1/1994
• Improved detection of perioperative myocardial infarction with cardiac troponin I.
  Adams J.E. III, Bodor G.S., Davila-Roman V.G., Sicard G.A., Ladenson J.H., Jaffe A.S., J Am Coll Cardiol, 1/1/1993
• Gender-dependent fibrinolytic effects of aspirin in humans.
  Adams J.E. III, Santoro S.A., Jaffe A.S., Circulation, 1/1/1993
• Improved detection of cardiac contusion with troponin I.
  Adams J.E. III, Davila-Roman V.G., Bessey P.Q., Blake D.P., Ladenson J.H., Jaffe A.S., Circulation, 1/1/1993
• Sensitivity of cardiac troponin I for detection of myocardial infarction.
  Landt Y, Adams J.E. III, Abendschein D.R., Jaffe A.S., Ladenson J.H., Clin Biochem Revs, 1/1/1993
• Specificity of cardiac troponin I for detection of myocardial injury.
  Adams J.E. III, Bodor G.S., Davila-Roman V.G., Ladenson J.H., Jaffe A.S., Circulation, 1/1/1992
• Join now to see all

Other

• "Guidelines for the Management of Unstable Angina and Non-ST Segment Elevation Acute Coronary Syndromes" 
  Jesse Earl Adams, III, MD, AHA Satellite Broadcast Conference
  6/12/2002